Categories Earnings, Other Industries

Honda’s Q3 earnings drop by 70%; sales remain flat

Honda Motor Company Ltd (HMC) reported consolidated sales revenue of JPY 3.97 trillion for the third quarter of 2019, relatively flat compared to the prior-year period, mainly due to higher sales revenue at motorcycle and financial services business operations, which was partially offset by negative foreign currency translation effects.

Profit attributable to owners of the parent declined 70.5% to JPY 168.2 billion compared to last year mainly due to impacts from the US tax reform last year. EPS decreased by JPY 222.89 to JPY 95.61 from last year.

Operating profit fell by 40.2% year-over-year to JPY 170.1 billion, mainly due to a drop in profit attributable to lower sales revenue and model mix.

Sales revenues increased across all business segments except for Automobile, which saw a slight drop from last year to JPY 2.8 trillion. The company also posted sales growth across all geographies except for Asia and Other Regions which saw declines.

Honda Q2 2019 Earnings: Motorbike giant speeds through results

For the full year of 2019, Honda expects sales revenue to increase 3.2% from 2018 to JPY 15.8 trillion. Profit attributable to owners of the parent is expected to drop 34.4% to JPY 695 billion. Diluted EPS is expected to be JPY 393.99.

The company declared a dividend of JPY 28 per common share for the third quarter. The total expected annual dividend per share of common stock is JPY 111 per share.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top